medigraphic.com
Coordinación General de Investigación de la Facultad de Salud Pública y Nutrición y la Dirección General de Sistemas e Informática de la Universidad Autónoma de Nuevo León

2006, Número 2

<< Anterior Siguiente >>

Rev Salud Publica Nutr 2006; 7 (2)


Mecanismos de adhesión al tracto intestinal y antagonismo de bifidobacterium

Iñiguez-Palomares C, Acedo-Félix E

Idioma: Español
Referencias bibliográficas: 157
Paginas:
Archivo PDF: 109.98 Kb.


RESUMEN

El género Bifidobacterium está integrado por bacilos Gram positivos que forman parte de la microflora normal del tracto intestinal de mamíferos. Como probiótico, uno de los beneficios que ofrecen estas bacterias, es inhibir la adhesión de patógenos en el intestino, tanto en humanos como en animales. Sin embargo, el mecanismo no está bien establecido. Las bacterias patógenas poseen proteínas de superficie tipo lectina, llamadas adhesinas, con las que reconocen carbohidratos (receptores) en la mucosa y/o epitelio. Dentro de ese reconocimiento también están involucradas interacciones de tipo hidrofílico e hidrofóbico. Mediante este mecanismo se adhieren y colonizan el tracto intestinal. En los microorganismos probióticos, la presencia de adhesinas, su papel en la colonización y desplazamiento de bacterias patógenas en el intestino empieza a investigarse.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Naidu, A.S., W.R. Bidlack and R.A. Clemens 1999. Probiotics spectra of lactic acid bacteria (LAB). Crit. Rev. in Food Sci. and Nutr. 38:13-126.

  3. Dunne, C., L.. O´Mahony, L.. Murphy, G.Thornton, D. Morrisen, S. O´Halloran, M. Feeney, S. Flynn, G. Fitzgerald, C. Daly, B. Kiely, G. O´Sullivan, F. Shanahan and J.K. Collins 2001. In vitro selection criteria for probiotic bacteria of human origin: correlation with in vivo findings. Am. J. of Clin. Nutr. 73(Supl.): 386S-392S.

  5. Prasad, J., H. Gill, J. Smart and P.K. Gopal, 1998. Selection and characterization of Lactobacillus and Bifidobacterium strains for use as probiotics. Int. Dairy J. 8:993-1002.

  7. Idem.

  9. Gómez-Zavaglia, A., G. Kociubinski, P. Pérez and G. De Antoni 1998. Isolation and characterization of Bifidobacterium strains for probiotic formulation. J. Food Prot. 61:865-873.

  11. Miller-Catchpole, R. 1989. Morphology of bifidobacteria En: Biochemistry and Physiology of Bifidobacteria. Bezkorovainy A y Miller-Catchpole R (editores). CRC Press . Boca Ratón, Florida. 73-89 pp

  13. Scardovi, V. 1986. Bergey´s Manual of Systematic Bacteriology. Vol. 2. Sneath PHA, Mair NS, Sharpe ME y Holt JG (eds) Williams and Wilkins. Baltimore, Londres, Los Angeles, Sydney. 1418-1434 pp.

  15. Ballongue, J. 1998. Bifidobacteria and probiotic action, En: Lactic Acid Bacteria. Microbiology and Functional Aspects. Segunda edición. Salminen S y von Wright A. Marcel Dekker, Inc. Nueva York. pp 519-587.

  17. Gomes, A.. F. Malcata, 1999. Bifidobacterium spp and Lactobacillus acidophilus: biological, biochemical, technological and therapeutical propierties relevant for use as probiotics. Trends Food Sci. and Technol. 10:139-157.

  19. Scardovi, V., Op. cit.

  21. Miller-Catchpole, R., Op. cit.

  23. Scardovi, V., Op. cit.

  25. Poupard, J.A., I. Husain, and R.F. Norris. 1973. Biology of the bifidobacterias. Bacteriol. Rev. 37: 136-165.

  27. Scardovi, V., Op. cit.

  29. Orban, J.I. and J.A. Patterson 2000. Modification of the phosphoketolase assay for rapid identification of Bifidobacteria. J. Microbiol. Methods. 40:221-224.

  31. Scardovi, V., Op. cit.

  33. BiavattI, B. and P. Mattarelli 1991. B. ruminantium sp. nov. and B. merycicum sp. nov. from cattle. Int. J. of Syst. Bacteriol. 41:163-168.

  35. Crociani, F., B. Biavatti, A. Alessandrim, C. Chiarini, and V. Scardovi 1996. B. inopinatum sp.nov. and B. denticolens sp.nov. Two new species isolated from human dental caries. Int. J. of Syst. Bacteriol. 46:564-571.

  37. Dong, X., Y. Xin, W. Jian, X. Liu, and D. Ling 2000. B. thermoacidophilum sp. nov. isolated from an anaerobic digester. Int. J. Syst. And Evol. Microbiol. 50:119-125.

  39. Hoyles, L., E. Inganäs, E. Falsen, N. Drancourt, M. Weiss, L. Mccartney and M.D. Collins, 2002. Bifidobacterium scardovii sp. nov., from human sources. Int. J. Syst. Evol. Microbiol. 52: 995-999.

  41. Lauer, E. 1990. Bifidobacterium gallicum sp. nov. isolated from human feces. Int. J. Syst. Bacteriol. 40:100-102.

  43. Meile, L.. W. Ludwing, U. Rueger, C. Gut, P. Kaufmann, G. Dasen, S. Wenger, and M. Teuber. 1997. Bifidobacterium lactis sp.nov. a moderately oxigen tolerant species isolated from fermented milk. Syst. Appl. Microbiol. 20:57-64.

  45. Scardovi, V., Op. cit.

  47. Watabe, J., Y. Benno, and T. Mitzuoka, 1983 Bifidobacterium gallinarum sp. nov: a new specie isolated from the ceca of chickens. Int. J. Syst. Bacteriol. 33:127-132.

  49. Macfarlane, G.T. and J.H. Cummings 1999. Probiotics and prebiotics: can regulating the activities of intestinal bacteria benefit health? British Med. J. 318: 999-1003.

  51. Corona, V. 2003.Evaluación probiótica de especies de Bifidobacterium en cerdos lactantes. Tesis de Maestría. Centro de Investigación en Alimentación y Desarrollo A.C. Hermosillo, Sonora, México.

  53. Fujiwara, S., H. Hashiba, T. Hirota, and J.F. Forstner, 1997. Proteinaceous factor(s) in culture supernatant fluids of Bifidobacteria wich prevents the binding of enterotoxigenic Escherichia coli to gangliotetraosylceramide. Appl. and Environm. Microbiol. 63:506-512.

  55. Kyriakis, S.C., V.K. Tsiloyiannis, J. Vlemmas, K. Sarris, A.C. Tsinas, C. Alexopoulos, and L. Jansegers 1999. The Effect of probiotic LSP 122 on the control of post-weaning diarrhoea syndrome of piglets. Res. Vet. Sci. 67:223-228.

  57. Marteau, P.R., M. De Vrese, C.J. Cellier, and J. Schrezenmeir, 2001. Protection from gastrointestinal diseases with the use of probiotics. Am. J. Clin. Nutr. 73(Suppl):430S-436S.

  59. Shu, Q., F. Qu, and H. Gill 2001. Probiotic tratment using Bifidobacterium lactis HN019 reduces weanling diarrhea associated with rotavirus and Escherichia coli infection in a piglet model. J. Ped. Gast. Nutr. 33:171-177.

  61. Yusof, R.M., F. Haque, M. Ismail, and Z. Asan 2000. Isolation of Bifidobacterium infantis and its Antagonic Activity Against ETEC 0157 and S. typhimurium S-285 in Weaning Foods. Asia Pacific J. Clin. Nutr. 9:130-135.

  63. Prasad, J., et. al, Op..cit.

  65. Macfarlane, G.T. and J.H. Cummings, Op. cit.

  67. Ouwehand, A.C. and P.L. Conway 1996. Purification and characterization of a component produced by Lactobacillus fermentum that inhibits the adhesion of K88 expressing Escherichia coli to porcine ileal mucus. J. Appl. Bacteriol. 80:311-318.

  69. Bibiloni, R., P.F. Pérez, G.R. Garrote, E.A. Disalvo, and G.L. De Antoni 2001. Surface characterization and adhesive properties of Bifidobacteria. Methods Enzymol. 336:411-427.

  71. Jonson, E. and P. Conway 1992. Probiotics for pigs. Probióticos. The Scientific Basis. R. Fuller ed. Chapman and Hall editorial. Gran Bretaña. 84-93 pp.

  73. Gómez-Zavaglia, A., G. Kociubinski, P. Pérez, E. Disalvo and G. De Antoni 2002. Effect of bile on the lipid composition and surface propierties of bifidobacteria. J. Applied Microbiol. 93:794-799.

  75. Ibrahim, S. and A. Bezkorovainy 1993. Survival of bifidobacteria in the presence of bile salt. J. of Sci. 62:351-354.

  77. Gueimonde, M., L. Noriega, A. Margolles, C. De Los Reyes-Gavilan, and S. Salminen 2005. Ability of Bifidobacterium Strains with Acquired Resistance to Bile to Adhere to Human Intestinal Mucus. Int. J. Food Microbiol. 101:341-346.

  79. Percival, M. 1997. Choosing a probiotic supplement. Clin. Nutr. Insig. 6:1-4.

  81. Doyle, M.E. 2001. Alternatives to antibiotic use for growth promotion in animal husbrandy. Food Research Institute. Abril.

  83. Fuller, R. 1999.Probiotics for far animals En: Probiotics. A critical review. Horizon Scientific Press. Wymondham, Gran Bretaña. pp 15-43.

  85. Ouwehand, A.C. and P.L. Conway, Op.cit.

  87. Maxwell, F.J. and C.S. Stewart 1995. Microbiology Gut En: The Neonatal Pig Development and Survival. M.A. Varley (Editor). CAB INTERNATIONAL (Editorial) Gran Bretaña. 162-174 pp

  89. Meng, Q.. M.S. Kerley, T.J. Russel, and G.L. Alle, 1998. Lectine-like activity of Escherichia coli K88, Salmonella choleraesuis and Bifidobacteria pseudolongum of porcine gastrointestinal origin. J. Anim. Scie. 76:551-556.

  91. Matsumoto, M., H. Tani, H. Ono, H. Ohishi, and Y. Benno 2002. Adhesive property Bifidobacterium lactis LKM512 and predominant bacteria of intestinal microflora to human intestinal mucin. Curr. Microbiol. 44:212-215.

  93. Dai, D., N.N. Nanthkumar, D.S. Newburg, and W.A. Walter 2000. Role of oligosaccharides and glycoconjugates in intestinal host defense. J. Ped. Gastroent. Nutr. 30 (Suppl) 2: 23S-33S.

  95. Mack, D.R., S. Michail, S. Wei, L. Mcdougall and M.A. Hollingsworth 1999. Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am. J. of Physiol. 276:941-950.

  97. Mouricout, M..1997.Interactions between the enteric pathogen and the host. an assorment of bacterial lectins and a set of glycoconjugate receptor. Adv. Exp. Med. Biol. 412:109-123.

  99. Ruseler-Van Embden, J.G., L.M. Van Lieshout, M.J. Gosselink, and P. Marteau 1995. Inability of Lactobacillus casei strain GG, Lactobacillus acidophilus and Bifidobacterium bifidum to degrade intestinal mucus glycoproteins. J. Gastroent. 30:675-680.

  101. Jin, L.Z., R.R. Marquardt and X. Zhao 2000. A Strain of Enterococcus faecium (18C23) inhibits adhesion of enterotoxigenic Escherichia coli K88 to porcine small intestine mucus. Appl. Environm. Microbiol. 66:4200-4204.

  103. Ouwehand, A.C. and P.L. Conway, Op.cit.

  105. Fujiwara, S., et. al., Op.cit.

  107. Fujiwara, S., H. Hashiba, T. Hirota, and J. Forstner 1999. Purification and characterization of a novel protein produced by Bifidobacterium longum SBT2928 that inhibits the binding of enterotoxigenic Escherichia coli Pb176 (CFA/II) to gangliotetraosylceramide. J. Appl. Microbiol. 86:615-621.

  109. Fontaine, J.F., E.A. Aissi, and S.J. Bouquelet 1994. In vitro binding of Bifidobacterium bifidum DSM 20082 to mucosal glycoproteins and hemagglutinating activity. Curr. Microbiol. 28:325-330.

  111. Greene, J.D. and T.R. Klaenhammer 1994. Factors involved in adherence of Lactobacilli to Human Caco-2 Cells. Appl. Environm. Microbiol. 60:4487-4494.

  113. Pérez, P.F. Y. Minnaard, E.A. Disalvo, and G.L. De Antoni 1998. Surface properties of Bifidobacterial strains of human origin. Appl Environm. Microbiol. 64:21-26.

  115. Busscher, H.J., G.I. Geertsema and H.C. Van Der Mei 1993. Mechanisms of oral microbial adhesion. J. of Appl. Bacteriol. 74 (Suppl):136S-146S.

  117. Crow, V.L., P.K. Gopal and A.J. Wiken 1995. Cell surface differences of Lactococal strains. Int. Dairy J. 5:45-68.

  119. Bibiloni, R., et. al., Op.cit.

  121. Pérez, P.F. et. al., Op.cit.

  123. Del Re, B., A. Busetto, G. Vignola, B. Sgorbati and D.L. Palenzona 1998. Autoaggregation and adhesión ability in a Bifidobacterium suis strain. Lett. Appl. Microbiol. 27:307-310.

  125. Del Re, B., B. Sgorbati, M. Miglioli and D. Palenzona 2000 Adhesión, autoaggregation and hydrophobicity of 13 Strains of Bifidobacterium longum. Lett. Appl. Microbiol. 31:438-442.

  127. Bibiloni, R., et. al., Op.cit.

  129. Pérez, P.F. et. al., Op.cit.

  131. Ballongue, J., Op.cit.

  133. Bibiloni, R., P.F. Pérez and G.L. de Antoni 1999. Factors envolved in adhesión of Bifidobacterial strains to epithelial cells in culture. Anaerobe. 5:483-485.

  135. Fontaine, J.F., et. al. Op. cit.

  137. Meng, Q..et. al. Op. cit.

  139. Ouwehand, A.C. and P.L. Conway, Op.cit.

  141. Maxwell, F.J. and C.S. Stewart, Op. cit.

  143. Idem.

  145. Sara, M. and B.S. Uwe 2000. S-Layer Proteins. J. Bacteriol. 182: 859-868.

  147. Fontaine, J.F., et. al. Op. cit.

  149. Bibiloni, R., et. al., Op.cit.

  151. Gao, W. and Q. Meng 2004. Lectin Activity and Chemical Characteristics of Escherichia coli, Lactobacillus spp. and Bifidobacterium spp. from GastrointestinalMucosa of Growing Pigs. Autral. J. of Animal Sci. 17:863-868.

  153. Meng, Q..et. al. Op. cit

  155. Rojas, M., F. Ascencio, and P. Conway 2002. Purification and characterization of a surface protein from Lactobacillus fermentum 104R that binds to porcine small intestinal mucus and gastric mucin. Appl. Environm. Microbiol. 68:2330-2336.

  157. Zhong, S., Z. Zhang, J. Wang, Z. Lai, Q. Wang, L. Pan and Y. Ren, 2004. Competitive inhibition of adherence of enterotoxigenic Escherichia coli, enteropathogenic Escherichia coli and Clostridium difficile to intestinal epithelial cell line Lovo by purified adhesin of Bifidobacterium adolescentis 1027. World J. Gastroent. 10:1630-1633.




2020     |     www.medigraphic.com